Hematology-Oncology Question Bank
Board-style questions with worked explanations.
Learning Tools
Upload a lecture; get a quiz, a deck, a video or a finished PowerPoint back.
Podcast Radio Station
Hem/onc podcast episodes sorted by topic, with a chat that finds the ones you ask for.
Chrome Extension
Make a flashcard from anything you are reading, without leaving the page.
OncoPulse
A personalized evidence digest. Free, and it emails you only when something matters.
AI PowerPoint Builder
Describe a talk and get an editable PowerPoint built from the papers, with the sources in the notes.
Attending Teaching Tools
Turn a case you just saw into a teaching session for your fellows.
Program Library
Your curriculum, your content, in one place for the whole cohort.
Program Director Dashboard
Cohort progress and weak areas, before the in-training exam finds them.
Ready-made teaching sessions your faculty can run as they are.
The verdict: no single resource covers the ABIM Hematology blueprint well enough to be your only prep tool, but they are not interchangeable either — ...
The verdict, from someone who sat the ABIM hematology certification exam this past cycle: you need a layered prep strategy, not a single book or cours...
The verdict: no single book covers the ABIM Hematology and Medical Oncology blueprints well enough to be your only resource[1][2][3]. If you are choos...
The verdict: if you are sitting the Medical Oncology Certification Exam this year, standard registration runs December 1, 2025 through June 15, 2026, ...
Short answer: The abbreviations that cause the most confusion in hematology and oncology are the ones that look alike but measure different things: ov...
Short answer: Myeloproliferative neoplasms (MPNs: polycythemia vera, essential thrombocythemia and primary myelofibrosis) are clonal diseases of effec...
Short answer: STARGLO was an open-label phase 3 trial of 274 transplant-ineligible patients with relapsed or refractory diffuse large B-cell lymphoma ...
Short answer: GRIFFIN was a randomized phase 2 trial of 207 transplant-eligible patients with newly diagnosed multiple myeloma. Adding daratumumab to ...
Short answer: KEYNOTE-826 was a double-blind phase 3 trial of 617 women with persistent, recurrent or metastatic cervical cancer not amenable to curat...
Short answer: OlympiAD was an open-label phase 3 trial of 302 patients with germline BRCA-mutated, HER2-negative metastatic breast cancer. Olaparib 30...
Short answer: Mediastinal gray zone lymphoma (MGZL) is a rare large B-cell lymphoma of young adults that sits between nodular sclerosis classical Hodg...
The verdict: disseminated intravascular coagulation (DIC) is not a single lab value, it is a clinical diagnosis built from two pieces: a predisposing ...
Posts 1–12 of 102
Frequently Asked Questions
Get answers about MeDucation
About Us
Learn about our mission and team
Start free trial
Start your board prep today